Cheng, Jie <br/><br/>
Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Oct 2010 
 - 32-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.110.170225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line<br/>Colon--metabolism<br/>Dextran Sulfate<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Inflammatory Bowel Diseases--chemically induced<br/>Leprostatic Agents--therapeutic use<br/>Liver--metabolism<br/>Luciferases--metabolism<br/>Male<br/>Metabolomics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Microsomes--metabolism<br/>NF-kappa B--biosynthesis<br/>Pregnane X Receptor<br/>RNA, Messenger--biosynthesis<br/>Receptors, Steroid--agonists<br/>Rifampin--therapeutic use<br/>Rifamycins--therapeutic use<br/>Rifaximin<br/>Stearoyl-CoA Desaturase--metabolism